Search

Search Constraints

You searched for: Author/Creator Bimoussa, Abdoullah

Search Results

1. Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1, 2, 3-triazole-isoxazoline hybrids using the eugenol as a precursors. Issue 7 (3rd May 2023)

2. Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies. Issue 5 (24th March 2023)

3. Design, Synthesis, Biological and Computational Assessment of New Thiazolidin‐4‐one Derivatives as Potential Anticancer Agents Through the Apoptosis Pathway. Issue 21 (1st June 2022)

4. Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1, 2, 3‐triazole Hybrids". Issue 1 (2nd January 2023)

5. Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis. (June 2022)

6. Diastereomerically pure (S)‐verbenone‐isoxazoline hybrids: Synthesis, molecular structure, Hirshfeld surface analysis, density functional theory, cytotoxic effect, and apoptosis induction. (24th September 2022)

7. Hemisynthesis, crystal structure and inhibitory effect of sesquiterpenic thiosemicarbazones and thiazolidin‐4‐ones on the corrosion behaviour of stainless steel in 1 M H2SO4 solution. Issue 6 (14th May 2019)

8. Hybrid of the 1, 2, 3‐triazole nucleus and sesquiterpene skeleton as a potential antitumor agent: Hemisynthesis, molecular structure, Hirshfeld surface analysis, density functional theory, and in vitro cytotoxic and apoptotic effects. (4th October 2021)

9. Novel Hydrazono‐2‐Iminothiazolidin‐4‐Ones Based on a Monoterpenic Skeleton as Potential Antitumor Agents: Synthesis, DFT Studies, in Vitro Cytotoxicity, Apoptosis Inducing Properties and Molecular Docking. Issue 7 (5th July 2022)

10. Novel isoxazoline‐linked 1, 3, 4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation. Issue 9 (20th May 2022)